Search
Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.
New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.
Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.
Get an inside look into the life of a student from the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences.
Everyone knows that cigarettes cause cancer. But what do we know about how they do it?
Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.
A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.
Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.
Memorial Sloan Kettering Cancer Center (MSKCC) is now poised to take greater advantage of a new era in cancer research and education with the opening of a state-of-the-art research center, the establishment of a new graduate school, and the founding of a novel research program in human oncology.
Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.